Product Information
QC STOMACH RLF 262 MG CAPLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0930 per EA under NDC 83324006040. Its NADAC has been published 81 times since Mar 19, 2025.
Strength
262 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324006040
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BISMUTH SUBSALICYLATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M008On Market Since
2/14/2025
Price Statistics
The NADAC for QC STOMACH RLF 262 MG CAPLET has been published 81 times since Mar 19, 2025, and over the history we have for it it has declined 11.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0930 per EA |
|---|---|
| All-time high | $0.1047 (Apr 16, 2025) |
| All-time low | $0.0875 (Mar 18, 2026) |
| 52-week high | $0.0992 |
| 52-week low | $0.0875 |
| Median price | $0.0932 |
| Average price | $0.0951 |
| Largest weekly change | -3.8% (Nov 19, 2025) |
| Weeks tracked | 81 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bismuth subsalicylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC STOMACH RLF 262 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for QC STOMACH RLF 262 MG CAPLET, manufactured by Chain Drug Marketing Association, is $0.0930 per EA (NDC 83324006040), effective Sep 30, 2026.
How has the price of QC STOMACH RLF 262 MG CAPLET changed over time?
Over the history we have for it, the NADAC for QC STOMACH RLF 262 MG CAPLET has declined 11.1%. It has been tracked across 81 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for QC STOMACH RLF 262 MG CAPLET?
Since Mar 19, 2025, the NADAC for QC STOMACH RLF 262 MG CAPLET has ranged from a low of $0.0875 (Mar 18, 2026) to a high of $0.1047 (Apr 16, 2025), with a median of $0.0932 per EA.
Are there cheaper alternatives to QC STOMACH RLF 262 MG CAPLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GNP PINK BISMUTH 262 MG TB CHW, is $0.0817 per EA — about 12% below QC STOMACH RLF 262 MG CAPLET.
Who manufactures QC STOMACH RLF 262 MG CAPLET?
QC STOMACH RLF 262 MG CAPLET (NDC 83324006040) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.